IMPORTANT LEGAL NOTICE - The information on this site is subject to adisclaimerand acopyright notice
 
Contact   |   Search  
Graphical element Graphical element Graphical element Graphical element Graphical element Graphical element Graphical element Graphical element Graphical element
Cell factory - Back to the homepage Graphic element Graphical element
Foreword Graphic element Graphical element
Table of contents Graphical element
Index by Index by Area Index by Partners Index by Keywords Graphic element Graphical element
Volume 2 Graphical element

a   |  b   |  c   |  d   |  e   |  f   |  g   |  h   |  i   |  j   |  k   |  l   |  m   |  n   |  o   |  p   |  q   |  r   |  s   |  t   |  u   |  v   |  w   |  x   |  y   |  z  |
Graphical element
 
Bacillus subtilis
  QLK3-2001-00519 Directed evolution of enantioselective biocatalysts (EvoCatal)
 
bead-based containment
  QLK3-2002-02063 Development and risk assessment of a field-based portable biosensor using genetically-modified bioluminescent bacteria (BIOGEM)
 
binding capacity
  QLK3-2002-02031 Neuropeptides for lung treatment of rare lung diseases, primary and secondary pulmonary hypertension (Neuropeotide Lung Therapy)
 
binding epitopes
  QLK3-2001-00498 Therapeutic molecules for modulation of ligand-receptor mediated apoptosis (Triskel)
 
biocatalysts
  QLK3-2002-02086 Exploiting the secretion machinery of Pseudomonas for the nanotechnological production of pharmaceuticals (NANOFOLDEX)
 
bioinformatics
  QLK3-2002-02032 Functional genomics and proteomics of Trichoderma antagonist strains for industry and agriculture (TRICHOEST)
 
biomineralisation
  QLK3-2001-00090 Stable extracellular matrices as novel biotherapeutics for biomimetic induction of hard tissue growth (MATRIX)
 
biosensors
  QLK3-2001-00101 Testing integrated GM-Rhizoremediation systems for soil bioremediation (GM-Rhizoremediation)
 
biosynthesis
  QLK3-2001-00435 Solvent tolerant bacteria allowing a broader performance of biotransformations of organic compounds in two phases (BARTOLO)
 
biotinylation
  QLK3-2001-02166 A Fusion Gene for the Treatment of Cancer (Scavidin)
 
bone marrow
  QLK3-2001-00506 Research, selection and mechanism of action of potential therapeutic agents against Flaviviridae (Hepatitis C virus, Dengue virus, West Nile virus) (Flavitherapeutics)
Graphical element
a   |  b   |  c   |  d   |  e   |  f   |  g   |  h   |  i   |  j   |  k   |  l   |  m   |  n   |  o   |  p   |  q   |  r   |  s   |  t   |  u   |  v   |  w   |  x   |  y   |  z  |
Graphical element